Tamarack Advisers, LP Pacira Bio Sciences, Inc. Transaction History

Tamarack Advisers, LP

$2.12 Billion
Q4 2023

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$35.53 - $43.38 $3.2 Million - $3.9 Million	-90,000 Reduced 90.0%	10,000 $408,000
Q4 2022 Feb 10, 2023	SELL	$38.19 - $57.45 $3.63 Million - $5.46 Million	-95,000 Reduced 48.72%	100,000 $3.86 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $1.02 Million - $1.18 Million	20,000 Added 11.43%	195,000 $10.4 Million
Q2 2022 Aug 16, 2022	SELL	$51.49 - $81.64 $1.54 Million - $2.45 Million	-30,000 Reduced 14.63%	175,000 $10.2 Million
Q1 2022 May 11, 2022	SELL	$60.03 - $76.49 $2.1 Million - $2.68 Million	-35,000 Reduced 14.58%	205,000 $15.6 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $6.48 Million - $8.4 Million	-135,000 Reduced 36.0%	240,000 $14.4 Million
Q3 2021 Nov 12, 2021	BUY	$54.64 - $61.3 $819,600 - $919,500	15,000 Added 4.17%	375,000 $21 Million
Q2 2021 Aug 13, 2021	SELL	$59.18 - $69.99 $11.2 Million - $13.3 Million	-190,000 Reduced 34.55%	360,000 $21.8 Million
Q1 2021 May 12, 2021	SELL	$59.31 - $78.82 $11 Million - $14.6 Million	-185,000 Reduced 25.17%	550,000 $38.6 Million
Q4 2020 Feb 10, 2021	BUY	$50.47 - $66.26 $4.04 Million - $5.3 Million	80,000 Added 12.21%	735,000 $43.6 Million
Q3 2020 Nov 12, 2020	SELL	$51.97 - $63.0 $2.34 Million - $2.84 Million	-45,000 Reduced 6.43%	655,000 $39.4 Million
Q2 2020 Aug 11, 2020	BUY	$30.8 - $52.47 $4.62 Million - $7.87 Million	150,000 Added 27.27%	700,000 $36.7 Million
Q1 2020 May 14, 2020	SELL	$28.4 - $50.7 $2.06 Million - $3.68 Million	-72,500 Reduced 11.65%	550,000 $18.4 Million
Q4 2019 Feb 11, 2020	SELL	$36.31 - $46.83 $5.54 Million - $7.14 Million	-152,500 Reduced 19.68%	622,500 $27.8 Million
Q3 2019 Nov 05, 2019	BUY	$35.66 - $44.99 $5.35 Million - $6.75 Million	150,000 Added 24.0%	775,000 $29.5 Million
Q2 2019 Aug 12, 2019	BUY	$36.57 - $47.97 $11.2 Million - $14.6 Million	305,000 Added 95.31%	625,000 $27 Million
Q1 2019 May 13, 2019	BUY	$36.47 - $42.17 $11.7 Million - $13.5 Million	320,000 New	320,000 $12.2 Million
Q4 2018 Feb 11, 2019	SELL	$41.31 - $52.16 $6.2 Million - $7.82 Million	-150,000 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$32.85 - $52.0 $1.31 Million - $2.08 Million	-40,000 Reduced 21.05%	150,000 $7.37 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $1.96 Million - $2.84 Million	71,298 Added 60.06%	190,000 $6.09 Million
Q1 2018 May 08, 2018	SELL	$29.98 - $46.35 $5.89 Million - $9.1 Million	-196,298 Reduced 62.32%	118,702 $3.7 Million
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $2.07 Million - $3.05 Million	65,000 Added 26.0%	315,000 $14.4 Million
Q3 2017 Nov 13, 2017	BUY	$35.7 - $39.5 $8.93 Million - $9.88 Million	250,000	250,000 $9.39 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$165 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$109 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$102 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$41.6 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$40.8 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $946M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Tamarack Advisers, LP with notifications on news.

Account